Clinical significance of secreted protein acidic and rich in cystein in esophageal carcinoma and its relation to carcinoma progression
Open Access
- 30 April 2003
- Vol. 97 (10) , 2412-2419
- https://doi.org/10.1002/cncr.11368
Abstract
BACKGROUND Secreted protein acidic and rich in cystein (SPARC) is a small extramatrix‐associated protein. Its production increases during angiogenesis and enhances matrix metalloproteinase‐2 (MMP‐2) expression. The goal of this study was to show the clinical relevance of SPARC and its relation to MMP‐2 expression in esophageal carcinoma patients. METHODS The authors investigated SPARC mRNA expression in 48 tissue samples of esophageal tumors characterized by MMP‐2 mRNA expression in a Northern blot analysis. Western blot analysis and immunohistochemistry were also performed in esophageal carcinoma tissue samples. RESULTS All 48 tissue specimens had high expression of SPARC mRNA. Quantitative evaluation showed that high SPARC mRNA was associated significantly with lymph node metastasis (P = 0.05) and poorer prognosis (P = 0.025). Expression of SPARC mRNA was associated significantly with MMP‐2 mRNA expression (R = 0.65; P < 0.01). Both SPARC and MMP‐2 were immunolocalized intensely in carcinoma and stromal cells, whereas normal esophageal mucosa and submucosa did not express SPARC. The 35‐kilodalton cleaved SPARC was detected in esophageal carcinoma tissue specimens by Western blot analysis and it was associated with MMP‐2 mRNA expression. CONCLUSIONS In terms of clinical significance, SPARC accumulation may reflect a functional correlation with MMP‐2 and the associated expression could play a key role in the progression of esophageal carcinoma. Cancer 2003;97:2412–9. © 2003 American Cancer Society. DOI 10.1002/cncr.11368Keywords
This publication has 32 references indexed in Scilit:
- Transcriptional upregulation of SPARC, in response to c-Jun overexpression, contributes to increased motility and invasion of MCF7 breast cancer cellsOncogene, 2002
- ANALYSIS OF THE GENE EXPRESSION OF SPARC AND ITS PROGNOSTIC VALUE FOR BLADDER CANCERJournal of Urology, 2001
- Genes Expressed in Human Tumor EndotheliumScience, 2000
- SPARC Regulates the Expression of Collagen Type I and Transforming Growth Factor-β1 in Mesangial CellsJournal of Biological Chemistry, 1999
- Terms of attachment: SPARC and tumorigenesisNature Medicine, 1997
- Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cellsNature Medicine, 1997
- Requirements for Transforming Growth Factor-β Regulation of the Pro-α2(I) Collagen and Plasminogen Activator Inhibitor-1 PromotersPublished by Elsevier ,1995
- Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin‐3 and BM‐40/SPARC genesInternational Journal of Cancer, 1995
- SPARC is a source of copper-binding peptides that stimulate angiogenesis.The Journal of cell biology, 1994
- Differential expression of SPARC and thrombospondin 1 in wound repair: immunolocalization and in situ hybridization.Journal of Histochemistry & Cytochemistry, 1993